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 23 
Abstract  24 
The colonic microbiota plays an important role in the bioavailibility of dietary 25 
polyphenols. This work has evaluated the impact on the gut microbiota of long-term 26 
feeding with both a red wine polyphenolic extract and the flavan-3-ol metabolizer strain 27 
Lactobacillus plantarum IFPL935. The study was conducted in the dynamic Simulator 28 
of the Human Intestinal Microbial Ecosystem (SHIME). The feeding of the gut 29 
microbiota model with red wine polyphenols caused an initial decrease in the counts of 30 
total bacteria in the ascending colon (AC), being Bacteroides, Clostridium 31 
coccoides/Eubacterium rectale and Bifidobacterium the most affected bacterial groups. 32 
The bacterial counts recovered to initial numbers faster than the overall microbial 33 
fermentation and proteolysis, which seemed to be longer affected by polyphenols. 34 
Addition of L. plantarum IFPL935 helped to promptly recover total counts, 35 
Lactobacillus and Enterobacteriaceae and led to an increase in lactic acid formation in 36 
the AC vessel at the start of the polyphenol treatment as well as butyric acid in the 37 
transverse (TC) and descending (DC) vessels after 5 days. Besides, L. plantarum 38 
IFPL935 favoured the conversion in the DC vessel of monomeric flavan-3-ols and their 39 
intermediate metabolites into phenylpropionic acids and in particular 3-(3´-40 
hydroxyphenyl)propionic acid. The results open possibilities of using L. plantarum 41 
IFPL935 as a food ingredient for helping individuals showing a low polyphenol-42 
fermenting metabotype to increase their colonic microbial capacities of metabolizing 43 
dietary polyphenols. 44 
Keywords Lactobacillus, polyphenol, colonic metabolism, probiotic, intestinal 45 
microbiota 46 
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Introduction 48 
 49 
Moderate consumption of red wine and/or regular consumption of other polyphenol-rich 50 
beverages and foods has proved in epidemiological studies to reduce the incidence of 51 
certain chronic diseases (Arranz et al. 2012; Kishimoto et al. 2013). Although the health 52 
effects of food polyphenols have been repeatedly associated with their free radical 53 
scavenging and antioxidant activity, recent evidence has, however, indicated that the 54 
effects of antioxidants are less relevant than expected (Tomás-Barberán and Andrés-55 
Lacueva 2012). The bioavailability, absorption and metabolism of polyphenolic 56 
compounds are, indeed, key issues required to explain their role in human health. 57 
Depending on their chemical structure and food matrix, a high percentage of dietary 58 
polyphenols are not absorbed in the small intestine, reaching the colon where they are 59 
metabolized by the gut microbiota before being absorbed. Likewise, polyphenols and 60 
their resultant metabolites may selectively modulate the gut microbial composition by 61 
their antimicrobial or eventually prebiotic-like properties (Queipo-Ortuño et al. 2012; 62 
Tzounis et al. 2008). In this sense, an increase in Lactobacillus and Bifidobacterium 63 
species following administration of red wine polyphenols has been reported (Dolara et 64 
al. 2005; Queipo-Ortuño et al. 2012). Moreover, a significant correlation of moderate 65 
wine consumption with human microbiome composition, but not with enterotype 66 
partitioning, has been established (Wu et al., 2011).  67 
Flavonoids are the most abundant polyphenols present in red wine, mainly 68 
including flavan-3-ols and anthocyanins (Waterhouse 2002). There are several 69 
metabolic pathways proposed for the catabolism of monomeric flavan-3-ol and dimeric 70 
procyanidins by the intestinal microbiota (Monagas et al. 2010; Selma et al. 2009). 71 
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However, bacterial degradation of flavan-3-ols is hindered by the inherent antibacterial 72 
effects of these molecules. In previous studies, we have reported that L. plantarum 73 
IFPL935 was capable to metabolize galloylated flavan-3-ols leading to the formation of 74 
gallic acid, pyrogallol and catechol through galloyl-esterase, decarboxylase and benzyl 75 
alcohol dehydrogenase enzyme activities, respectively (Tabasco et al. 2011). The most 76 
remarkable feature of L. plantarum IFPL935 was its ability to cleave the heterocyclic 77 
ring of monomeric flavan-3-ols, giving rise to 1-(3',4'-dihydroxyphenyl)-3-(2'',4'',6''-78 
trihydroxyphenyl)-propan-2-ol (i.e. diphenylpropanol), which is the first metabolite in 79 
the microbial catabolic pathway of flavan-3-ols (Sánchez-Patán et al. 2012b). This 80 
activity has only been reported in a few intestinal bacteria to date, such as Eubacterium 81 
sp. SDG-2, Eggerthella lenta, and Flavonifractor plautii (Jin and Hattori 2012; 82 
Kutschera et al. 2011; Wang et al. 2001). The capability of L. plantarum IFPL935 to 83 
initiate the catabolism of flavan-3-ols via the formation of diphenylpropanol has also 84 
been demonstrated when the strain was incubated in batches with a complex human 85 
intestinal microbiota (Barroso et al., 2013). It was also observed that the addition of this 86 
strain had an impact on the formation of butyric acid, probably through cross-feeding 87 
with colonic butyrate-producing bacteria (Barroso et al., 2013).   88 
To get a deeper insight on the potential use of L. plantarum IFPL935 to benefit 89 
polyphenols metabolism we have monitored the effect on the gut microbiota upon 90 
addition of 10
10
 cfu of the strain to a daily intake of a polyphenolic extract (equivalent 91 
to two 125 ml-glasses of alcohol-free red wine) in a long-term feeding experiment.  The 92 
study was conducted in the dynamic multireactor gastrointestinal Simulator of the 93 
Human Intestinal Microbial Ecosystem (SHIME). 94 
 95 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
5 
 
Materials and methods 96 
 97 
Simulator of the Human Intestinal Microbial Ecosystem (Twin-SHIME) 98 
In this study, a Twin-SHIME
®
 (UGent/ProDigest) setup was used by operating two 99 
parallel SHIME systems, each one consisting of five consecutive reactors, simulating 100 
the stomach, small intestine, ascending colon (AC), transverse colon (TC), and 101 
descending colon (DC), as described by Van den Abbeele et al. (2010). At the 102 
beginning of the experiment, the AC, TC and DC vessels from the Twin-SHIME 103 
systems were all simultaneously inoculated with the same fecal sample from a healthy 104 
human volunteer previously identified as a flavan-3-ol metabolizer (unpublished results) 105 
to enable comparison of the results between the two parallel experiments. The colonic 106 
microbiota was allowed for stabilization reaching the steady state after 3 weeks. The 107 
inoculum preparation and the SHIME feed composition during the stabilization period 108 
were essentially as described by De Boever et al. (2004). After stabilization of the 109 
colonic microbiota, both Twin-SHIME systems were subjected to a 2-week experiment 110 
by daily feeding the stomach compartments  with 200 mg of a commercial red wine 111 
extract, Provinols
TM
 (Safic-Alcan Especialidades, Barcelona, Spain), which corresponds 112 
to a daily polyphenol intake of two small glasses of red wine (250 ml). The total 113 
phenolic content of the red wine extract was 474 mg of gallic acid equivalents per g 114 
(2.79 mmol/g) and its composition was reported before (Sánchez-Patán et al. 2012a), 115 
being flavan-3-ols the main phenolic compounds. In addition, one of the Twin-SHIME 116 
systems was simultaneous fed with a daily dose of 10
10
 cfu of Lactobacillus plantarum 117 
IFPL935. Finally, a 1-week wash-out period was included at the end of the experiment 118 
for both systems. During the whole study, samples were collected at regular time points 119 
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from the three colon vessels and stored at −20 °C until further analysis, excepting for 120 
microbiological plate counts that were performed at the time of sampling.  121 
 122 
Bacterial culture conditions and plate counts 123 
Lactobacillus plantarum IFPL935 (CECT 4599) was routinely grown aerobically at 37 124 
°C in MRS broth. To reach the daily supplementation of 10
10
 cfu of IFPL935, 10 ml of 125 
L. plantarum IFPL953 grown to 10
9
 cfu/ml were added daily to the stomach 126 
compartment in one of the SHIME systems, right after the addition of the red wine 127 
extract. Numbers of lactobacilli in the inoculum were counted using MRS-agar plates 128 
and in the AC, TC and DC vessels using LAMVAB agar (Hartemink et al. 1997), and 129 
plates were incubated aerobically at 37 °C for 48 h. Total aerobes and total anaerobes 130 
were determined by plating on BHI agar and incubation at 37 °C for 24 h aerobically or 131 
72 h anaerobically, respectively. Total coliforms were enumerated in MacConkey agar 132 
incubated for 24 h aerobically at 37 °C. 133 
 134 
DNA extraction and analysis 135 
Bacterial DNA was extracted using hexadecyltrimethylammonium bromide (CTAB) 136 
buffer and phenol-chloroform-isoamyl alcohol and bead-beating, as described 137 
previously (Griffiths et al. 2000; Kowalchuk et al. 1998). The DNA was precipitated 138 
with polyethelene glycol (PEG-6000), washed in ice cold 70% ethanol and dried in a 139 
Speed-Vac, prior to resuspension in distilled water. The concentration and quality of the 140 
samples were assessed with a Nanodrop spectrophotometer (Thermo Fisher Scientific, 141 
Wilmington, DE, USA). 142 
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Quantitative PCR (qPCR) 143 
Bacterial numbers in the AC, TC and DC vessels were quantified by qPCR using SYBR 144 
green methodology (Kappa Biosystems, Woburn, MA, USA) with the IQ5 Multicolor 145 
Real-Time PCR Detection System and data analyses (Bio-Rad Laboratories Inc., 146 
Hercules, CA, USA). The bacterial groups targeted for qPCR were total bacteria, 147 
Lactobacillus, Bifidobacterium, Bacteroides, Enterobacteriaceae, and the specific 148 
phylogenetic groups Clostridium coccoides-Eubacterium rectale Cluster XIVa, 149 
Ruminococcus Cluster IV, and Clostridium leptum subgroup specific cluster IV. 150 
Butyrate-producing bacteria were also estimated by quantifying the gene encoding 151 
butyryl-CoA:acetate CoA transferase (BcoAT). Primers, amplification conditions and 152 
calculation of copy numbers have been detailed previously (Barroso et al. 2013). DNA 153 
from Escherichia coli DH5α, L. plantarum IFPL935, Bifidobacterium breve 29M2 and 154 
Bacteroides fragilis DSM2151 was used for quantification of total bacteria, 155 
Lactobacillus, Bifidobacterium and Bacteroides, respectively. For the rest of groups 156 
analyzed, samples were quantified using standards derived from targeted cloned genes 157 
using the pGEM-T cloning vector system kit (Promega, Madison, WI, USA), as 158 
described previously (Barroso et al., 2013). 159 
PCR-DGGE 160 
The diversity of the Lactobacillus community in the AC, TC and DC vessels and the 161 
presence of L. plantarum were assessed by PCR-DGGE and using the primers Lab-162 
159F and Uni-515-GC-R, as described by Heilig et al. (2002). DGGE was performed 163 
with a DCode system (Bio-Rad) using a 9% polyacrylamide gel with a 30–50% gradient 164 
of 7 M urea and 40% formamide. The obtained band patterns were analyzed using 165 
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InfoQuest FP software version 5.1 (Bio-Rad). Clustering was performed with Pearson 166 
correlation and the UPGMA method. 167 
 168 
Bacterial metabolism 169 
Analysis of short and branched-chain fatty acids (SCFA and BCFA), lactic acid and 170 
ammonium  171 
The SCFA and BCFA were extracted from the samples with diethyl ether, after the 172 
addition of 2-methyl hexanoic acid as an internal standard and extracts were analysed 173 
by GC as described previously (Possemiers et al. 2004). SCFA were separated using a 174 
capillary free fatty acid packed column (EC-1000 Econo-Cap, 25 m × 0.53 mm x 1.2 175 
µm) and detected with a flame ionization detector. Nitrogen was used as carrier gas. 176 
Lactic acid was measured spectrometrically with an enzymatic D-/L-lactic acid Kit (R-177 
Biopharm, Darmstadt, Germany), according to the manufacturer's instructions. 178 
Ammonium was released from samples as ammonia by addition of MgO and 179 
distillation into boric acid-indicator solution using an autodistillation Vapodest 30´ 180 
(Gerhardt Analytical Systems, Brackley Northants, UK), as earlier described by 181 
Bremner and Keeney (1965). Ammonia was determined by titration with standard HCl 182 
using a 685 Dosimat and 686 Titroprocessor (Metrohm, Berchem, Belgium). 183 
Analysis of phenolic metabolites 184 
Phenolic metabolites were analyzed by a previous UPLC-ESI-MS/MS method 185 
(Sánchez-Patán et al. 2011) further implemented (Jiménez-Girón et al. 2013). The liquid 186 
chromatographic system was a Waters Acquity UPLC (Milford, MA, USA) equipped 187 
with a binary pump, an autosampler thermostated at 10 ºC, and a heated column 188 
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compartment (40 ºC). The column employed was a BEH-C18, 2.1 x 100 mm and 1.7 189 
µm particle size from Waters (Milford, MA, USA). The mobile phases were 2% acetic 190 
acid in water (A) and 2% acetic acid in acetonitrile (B). The gradient program was as 191 
follows: 0 min, 0.1% B; 1.5 min, 0.1% B; 11.17 min, 16.3% B; 11.5 min, 18.4% B; 14 192 
min, 18.4% B; 14.1 min, 99.9% B; 15.5 min, 99.9% B; 15.6 min, 0.1% B. Equilibrium 193 
time was 2.4 min resulting in a total runtime of 18 min. The flow rate was set constant 194 
at 0.5 ml/min and injection volume was 2 l. The LC effluent was pumped to an 195 
Acquity TQD tandem quadrupole mass spectrometer equipped with a Z-spray 196 
electrospray ionization (ESI) source operated in negative polarity mode. The ESI 197 
parameters were set as follows: capillary voltage, 3 kV; source temperature, 130 ºC; 198 
desolvation temperature, 400 ºC; desolvation gas (N2) flow rate, 750 l/h; cone gas (N2) 199 
flow rate, 60 l/h. The ESI was operated in negative ionization mode. For quantification 200 
purposes, data were collected in the multiple reaction monitoring (MRM) mode, 201 
tracking the transition of parent and product ions specific to each compound. The 202 
MS/MS parameters (cone voltage, collision energy and MRM transition) of the 60 203 
phenolic compounds targeted in the present study (mandelic acids, benzoic acids, 204 
phenols, hippuric acids, phenylacetic acids, phenylpropionic acids, cinnamic acids, 4-205 
hydroxyvaleric acids and valerolactones) were previously reported (Jiménez-Girón et al. 206 
2013). All metabolites were quantified using the calibration curves of their 207 
corresponding standards, except for 4-hydroxy-5-(3’,4’-dihydroxyphenyl)-valeric, and 208 
4-hydroxy-5-(phenyl)-valeric acids) which were quantified using the calibration curves 209 
of 3-(3’,4’-dihydroxyphenyl)-propionic, and propionic acids, respectively. Data 210 
acquisition and processing was realized with MassLynx 4.1 software. 211 
 212 
Statistical analysis 213 
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Mean values, standard deviations and correlation coefficients were calculated on the 214 
basis of the values for the different variables during the incubation period (microbial 215 
groups, SCFAs, acetate, propionate, butyrate, ammonium and phenolic metabolites). 216 
Analysis of variance (ANOVA) was used for multiple comparisons of the different 217 
variables taken into account different factors (time, compartments, and addition of L. 218 
plantarum IFPL935) (P < 0.05). All statistical analyses were carried out using the 219 
STATISTICA program for Windows, version 7.1 (StatSoft. Inc. 1984−2006, 220 
www.statsoft.com). 221 
 222 
 223 
Results 224 
Microbiological changes 225 
The colonic microbiota was allowed to reach the steady-state conditions during the 3-226 
weeks period of stabilization in each of the three colon vessels of the Twin-SHIME 227 
systems (Day 0, Table 1). After this stabilization period, impact of daily feeding with 228 
either the phenolic extract or the phenolic extract and L. plantarum IFPL935 on log 229 
numbers of total bacteria, Lactobacillus, Bifidobacterium, Bacteroides and 230 
Enterobacteriaceae, is shown in Table 1. Figure 1 shows the log numbers for the 231 
butyrate- producing phylogenetic groups C. coccoides-E. rectale Cluster XIVa,  C. 232 
leptum subgroup specific Cluster IV, and Ruminococcus Cluster IV. Feeding the 233 
SHIME with the phenolic extract caused a decrease of approx. 1 log numbers of total 234 
bacteria in the AC vessels after 24 h treatment (Table 1). This initial decrease of 235 
numbers affected mostly to the counts of Lactobacillus, Bifidobacterium, Bacteroides, 236 
Enterobacteriaceae (Table 1) and C. coccoides/E. rectale (Fig. 1). In most cases, 237 
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bacterial numbers were readily recovered after the first week of treatment. The largest 238 
reduction in numbers was recorded for Bacteroides, showing a decrease of 2 log 239 
numbers in the AC vessels at the first day of treatment. The inhibitory effect of the red 240 
wine extract was less pronounced but more persistent for Bifidobacterium, which 241 
numbers continuously fell down during the first week of treatment and did not recover 242 
until the second week. Addition of L. plantarum IFPL935 to one of the Twin-SHIME 243 
systems together with the phenolic extract resulted in relative stable numbers 244 
throughout the treatment of total bacteria, Lactobacillus and Enterobacteriaceae (Table 245 
1). In these bacterial groups, no impact of phenolic extract on the log numbers after 1 246 
day of treatment was observed with the presence of L. plantarum IFPL935. The 247 
diversity of lactobacilli in the AC, TC and DC vessels was followed by PCR-DGGE 248 
targeting the Lactobacillus genus. The cluster analysis of the DGGE profiles grouped 249 
the samples during the treatment period mainly based on the addition of L. plantarum 250 
IFPL935 to the SHIME feeding medium (Fig. S1 in the supplemental material). 251 
Additionally, agar plate counts revealed higher lactobacilli values during the treatment 252 
and first days of wash out in the colonic vessels of the SHIME unit supplemented with 253 
L. plantarum IFPL935 (results not shown).  254 
The numbers of the butyrate-producing bacteria group C. coccoides-E. rectale 255 
was equally represented in the three colonic vessels at the start of the treatment (about 7 256 
log), whereas C. leptum and Ruminococcus prevailed in TC and DC vessels (about 6-7 257 
log) (Fig. 1), being almost under the detection limit in the AC vessels. Impact of feeding 258 
the Twin-SHIME units with the phenolic extract on these three bacterial groups was 259 
more pronounced in the AC vessels for C. coccoides-E. rectale and in the TC vessels 260 
for C. leptum and Ruminococcus, where the effects appeared earlier in time. The 261 
BCoAT gene numbers corresponded with the results of butyrate producing bacteria 262 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
12 
 
counts, showing higher values in the TC and DC vessels than in the AC ones and, 263 
particularly, in the DC from the SHIME unit supplemented with L. plantarum IFPL935 264 
(results not shown).  265 
 266 
Wine polyphenols supplementation affects microbial metabolism 267 
Evolution of the microbial metabolism (fermentation and proteolysis) expressed as the 268 
content in SCFA, lactic acid, BCFA and ammonium is shown in Fig. 2. Daily intake of 269 
the polyphenolic extract caused a sharp decrease in both fermentation and proteolysis 270 
measured during the first days of treatment in all the AC, TC and DC vessels. 271 
Proteolysis rate measured by ammonium and BCFA content showed the minimum 272 
values in all vessels during the first week of treatment, particularly for ammonium. No 273 
differences were observed between both treatments with and without L. plantarum 274 
IFPL935 (Fig. 2A). Regarding the fermentation profile, acetic and propionic acid values 275 
decreased similarly, reaching minimum values in all three vessels during the first three 276 
days for both treatments (Fig. 2B). Butyric acid was lessened to no detectable levels 277 
during the first two days of treatment in all the vessels excepting the DC and TC vessels 278 
added with phenolic extract and L. plantarum IFPL935 (Fig. 2C). On the other hand, the 279 
lactic acid content was not negatively affected by any of the treatments. Moreover, the 280 
AC vessel of the SHIME supplemented with the phenolic extract and L. plantarum 281 
IFPL935 showed an increase of lactic acid at the starting of the intervention period and 282 
a decrease associated to the recovery of butyrate content to initial levels (Fig. 2C). The 283 
addition of L. plantarum IFPL935 also caused differences in the production of butyric 284 
acid in the DC vessels where the highest values for this acid were found. In general, the 285 
microbial metabolic activity present at the start of the feeding was recovered in all 286 
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vessels for both treatments after 5 days of the experiments, except for the production of 287 
butyric acid in the DC vessel without L. plantarum IFPL935, which only returned to 288 
initial values at the end of the wash-out period (Fig. 2C).  289 
 290 
Changes in phenolic metabolism 291 
Within the 60 phenolic metabolites targeted, a total of 26 compounds including benzoic 292 
acids, phenols, phenylacetic acids, phenylpropionic acids, valeric acids, valerolactones 293 
and cinnamic acids, exhibiting different substitutions in the aromatic ring, were 294 
quantified in the AC, DC and TC contents during the 2-weeks period of treatments and 295 
the wash-out period (Table S1 in the supplemental material). Formation of these 296 
metabolites was in accordance with disappearance of wine phenolic precursors (Table 297 
S2 in the supplemental material), mainly flavan-3ols (monomers and dimeric 298 
procyanidins), but also anthocyanins, flavonols and stilbenes. To better summarize these 299 
changes, Fig. 3 displays the sum of concentrations of the precursor monomers (+)-300 
catechin and (-)-epicatechin, and procyanidins B1, B2, B3, B4 (Fig. 3A), the 301 
intermediate metabolites phenyl-γ-valerolactones and phenylvaleric acid derivatives 302 
(Fig. 3B) and the phenylpropionic and phenylacetic acid derivatives (Fig. 3C) during 303 
the continuous feeding of the Twin-SHIME with the red wine polyphenolic extract. 304 
Flavan-3-ol monomers and procyanidins were mainly detected in AC vessels 305 
and starting from day 2 of the wine polyphenol treatment. The concentration of these 306 
precursor compounds in the AC vessels increased during the intervention, followed by a 307 
return to baseline during the wash-out period (Figure 3A). Precursors were also detected 308 
in the TC compartments, but their concentration diminished earlier than in the AC 309 
vessels. Interestingly, the content of these flavan-3-ol monomers and procyanidins in 310 
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TC and DC vessels were lower in the SHIME unit supplemented with L. plantarum 311 
IFPL935.  312 
The formation of 5-(3′,4′-dihydroxyphenyl)-γ-valerolactone and 4-hydroxy-5-313 
(3′,4′-dihydroxyphenyl)-valeric acid, intermediate metabolites arising from first steps in 314 
the microbial degradation of flavan-3-ols, was mainly observed in the TC vessels and 315 
their concentration increased after day 4 of both treatments (Fig. 3B). These compounds 316 
were also present in the DC vessels but to a much lesser extent and only in those with 317 
no addition of L. plantarum IFPL935. In accordance with these results, 4-hydroxy-5-318 
(phenyl)-valeric acid content increased with time and was mainly detected in the DC 319 
vessels (Table S1 in the supplemental material).  320 
Also, and as derived from galloylated flavan-3-ols, an increase in the content of 321 
gallic acid was only detected in the AC vessels, whereas 3-O-methylgallic acid was also 322 
measured in the TC vessels (Table S1 and Fig S2 in the supplemental material). 323 
Likewise, pyrogallol formation was only observed in the AC vessels whereas 324 
pyrocatechol was measured mainly in the AC and TC compartments. Supplementation 325 
with L. plantarum IFPL935 did not cause differences in the metabolism of these 326 
compounds.  327 
The evolution of 3-(4´-hydroxyphenyl) propionic acid, 4-hydroxyphenylacetic 328 
acid and phenylacetic acid, which can also be derived from aromatic amino acid 329 
catabolism, followed the same trends as the microbial metabolites released from 330 
proteolysis depicted in Fig. 2A (Table S1 in the supplemental material). The extent of 331 
formation of microbial phenolic metabolites from the flavan-3-ol compounds was 332 
estimated in the SHIME vessels during the treatment and wash-out periods by 333 
computing the formation of phenylpropionic acids [3-(3´,4´-dihydroxyphenyl)-334 
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propionic, 3-(3´-hydroxyphenyl)-propionic, and 3-phenylpropionic] and phenylacetic 335 
acids [3,4-dihydroxyphenylacetic and 3-hydroxyphenylacetic] derivatives (Fig. 3C). 336 
The highest values of these metabolites were observed in the DC vessels, being still 337 
detected during the wash-out period. In the SHIME unit supplemented with L. 338 
plantarum IFPL935 the phenylpropionic acid derivatives, mainly represented by 3-(3´-339 
hydroxyphenyl)propionic acid, appeared at earlier stages than the phenylacetic acid 340 
metabolites and their concentration was the highest when comparing values from the 341 
two SHIME units.  342 
 343 
Discussion 344 
The human gut microbiota contributes to many of the important host metabolic 345 
functions, including the increase of bioavailabilityof dietary polyphenols (van 346 
Duynhoven et al. 2011). Conversely, polyphenols and their resultant metabolites can 347 
modify the gut bacterial population composition and activity (Requena et al. 2010). 348 
Most of the studies that have examined the antimicrobial effect of dietary polyphenols 349 
have focused on single polyphenol molecules and/or single strains. In this work, we 350 
have studied the effect on the gut microbiota of the long-term feeding with a red wine 351 
polyphenolic extract and the impact of the supplementation of L. plantarum IFPL935, 352 
previously characterized as a flavan-3-ol metabolizer (Barroso et al. 2013; Sánchez-353 
Patán et al. 2012b). We have conducted the study in the in vitro model of the human 354 
intestinal microbiota SHIME, which has demonstrated to allow nutritional interventions 355 
with repeated doses to evaluate long-term effect of food ingredients on the microbiota 356 
allocated in three consecutive colon regions (Grootaert et al. 2009; Marzorati et al. 357 
2010; Van de Wiele et al. 2007; Van den Abbeele et al. 2013).  358 
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The present study shows that the initial addition of red wine polyphenols exerted 359 
an overall antimicrobial effect on the gut microbiota in the AC, but the effect 360 
disappeared during continuous feeding with polyphenols, probably due to the onset of 361 
microbial metabolism of polyphenols. The antimicrobial effect of red wine and grape 362 
polyphenolic extracts following either a single dose or a continuous feeding of the 363 
SHIME has recently been described (Kemperman et al. 2013). These authors reported a 364 
more pronounced antimicrobial effect on the colonic microbiota, which did not fully 365 
recover until the wash-out period. Differences between studies could be due to the fact 366 
that the amount of polyphenolic compounds daily supplemented by Kemperman et al. 367 
(2013) was 5-times higher than in the present study. Besides, grape extracts have 368 
demonstrated higher antimicrobial capacity than extracts obtained from red wine (Cueva 369 
et al. 2013), probably because of a higher content of proanthocyanidins and gallate 370 
derivatives (Xia et al. 2010).   371 
Among polyphenols, flavan-3-ols and flavonols have received most attention 372 
due to their wide spectrum and higher antimicrobial activity in comparison with other 373 
polyphenols (Daglia 2012). In our study, all bacterial groups analyzed in the AC vessels 374 
were initially affected by the supplementation with red wine polyphenols. Among them, 375 
Bacteroides and the butyrate-producers C. coccoides/E. rectale were the most affected 376 
groups, whereas Bifidobacterium showed a more persistent effect. Bacteroides and 377 
Bifidobacterium have been described previously (Kemperman et al. 2013) as the genera 378 
most affected after feeding the SHIME colonic microbiota with black tea and red wine 379 
polyphenols. Additionally, intake of flavan-3-ol-rich sources for prolonged periods of 380 
time has generally correlated with the decrease of Clostridium groups (Dolara et al. 381 
2005; Tzounis et al. 2011; Wu et al. 2011). On the other hand, counts of lactobacilli are 382 
generally unaffected or moderately increase after intake of diets enriched in flavanols 383 
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(Tzounis et al. 2011). Nevertheless, a different sensitivity to the presence of flavan-3-ols 384 
in the growth medium has been described for several Lactobacillus species (Tabasco et 385 
al. 2011), ranging from the optimal growth observed for L. plantarum, L. casei, and L. 386 
bulgaricus strains and the growth inhibition of L. fermentum, L. acidophilus and L. 387 
vaginalis. Among the strains assayed, however, only L. plantarum IFPL935 was able to 388 
metabolize flavan-3-ol compounds (Fernández-Patán, 2012b; Tabasco et al. 2011).  389 
Although the antimicrobial effect caused by daily feeding the SHIME with red 390 
wine polyphenols was predominantly observed during the first 1-2 days of treatment 391 
and it was more distinguished in the AC vessels, the inhibitory effect on the overall 392 
microbial metabolism, however, was similar in the three vessels and it lasted for the 393 
first 5 days of treatment (Fig. 2). These results indicate a more pronounced effect of the 394 
polyphenol compounds in the microbial functionality than in its viability. The initial 395 
exposure to polyphenols may up-regulate polyphenol-induced stress responses related to 396 
defensive mechanisms while simultaneously down-regulating various metabolic 397 
functions, for example, carbon and energy metabolism (Stevenson and Hurst 2007). 398 
Decreased rate of microbial fermentation and proteolysis, determined as reduction in the 399 
formation of SCFA and BCFA, is associated with high tannin-rich feeds intake in 400 
ruminant livestock (Bodas et al. 2012). The effects of some plant extracts have been 401 
described to last only a few days, indicating that ruminal microorganisms adapt to the 402 
compounds with time (Busquet et al. 2005). Similarly, the regular feeding of the 403 
SHIME with a red wine polyphenolic extract was able to introduce microbial and 404 
metabolic changes until the microbiota adapted its metabolism and returned to steady 405 
state similar conditions during the treatment.  406 
In terms of microbial metabolism, the addition of L. plantarum IFPL935 caused 407 
an increase in the formation of lactic acid at the start of the polyphenol treatment in the 408 
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AC vessel and of butyric acid in the TC and DC vessels after the day 5 of treatment 409 
(Fig. 2). The increased formation of butyric acid in the DC vessel supplemented with L. 410 
plantarum IFPL935 was also associated with a lower content of lactic acid. Both 411 
phenomena can partially be explained by the recovery at this point of the counts of 412 
butyrate-producing bacteria from clostridial cluster XIVa and eventually by bacterial 413 
cross-feeding production of butyric acid from lactic acid. In fact, the only vessels where 414 
the content of butyric acid did not decrease to zero values at the start of the polyphenol 415 
treatment were the TC and DC vessels of the SHIME supplemented with L. plantarum 416 
IFPL 935 (Fig. 2). Duncan et al. (2004) reported that most of the faecal species that 417 
utilize lactate to produce butyrate via the butyryl CoA:acetate CoA transferase route, 418 
belong to the clostridial cluster XIVa (Lachnospiraceae). The results obtained in this 419 
study confirm the previously observed effect of L. plantarum IFPL935 to increase the 420 
formation of butyric acid during batch incubations with different colonic microbiota 421 
(Barroso et al. 2013). This compound has been described as beneficial for human health 422 
since low prevalence in the gut has been associated with chronic immune or metabolic-423 
related diseases including inflammatory bowel disease (Frank et al. 2007) and obesity 424 
(Le Chatelier et al. 2013).The capability of L. plantarum IFPL935 to initiate the 425 
catabolism of polyphenols either via galloyl-esterase, decarboxylase and benzyl alcohol 426 
dehydrogenase activities (Tabasco et al. 2011) or mostly by the cleavage of the 427 
heterocyclic ring of monomeric flavan-3-ols (Sanchez-Patán et al. 2012b), might have 428 
contributed to diminish the inhibitory effect of the red wine extract when both were 429 
added to the SHIME units. So far and besides this strain, only a few bacterial strains, 430 
such as Eubacterium sp. SDG-2, Eggerthella sp. CAT-1, Eggerthella lenta rK3, and 431 
Flavonifractor plautii aK2 have been reported to be able to initiate the metabolism of 432 
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flavanol-3-ols by cleavage of the heterocyclic C-ring (Jin and Hattori 2012; Kutschera 433 
et al. 2011; Wang et al. 2001). 434 
A lower concentration of monomeric flavan-3-ols and first and intermediate 435 
metabolites (5-(3′-hydroxyphenyl)-γ-valerolactone and 4-hydroxy-5-(3′-436 
hydroxyphenyl)valeric acid), mainly represented in the AC and TC vessels, was 437 
observed in the vessels of the SHIME unit supplemented with L. plantarum IFPL935. In 438 
addition, further metabolism of the polyphenol intermediate compounds to the 439 
formation of phenylpropionic acids was detected earlier and reached higher 440 
concentrations in the DC vessel containing the strain when compared to the other 441 
colonic vessels (Fig. 3C). For both treatments, bacterial conversion of red wine 442 
polyphenols was more favorable in the distal colon, which is in agreement with 443 
previous studies where a higher microbial conversion of phenolic compounds was found 444 
in the distal compartments (Barroso et al. 2013; Van Dorsten et al. 2012).  445 
Phenyl propionic acid and 3-(3´-hydroxyphenyl)propionic acid were the 446 
microbial metabolites that accounted most for the differences between treatments. 447 
Phenylpropionic acid derivatives are considered to arise from β-oxidation of 448 
phenylvaleric acid derivatives (Monagas et al. 2010), except for 3-(4´-449 
hydroxyphenyl)propionic acid that can result from the microbial catabolism of tyrosine 450 
(Russell et al. 2013). The evolution of this compound during the SHIME treatment with 451 
red wine polyphenols indicated that 3-(4´-hydroxyphenyl)propionic acid aroused mostly 452 
from amino acid catabolism (Table S1 in the supplemental material). The phenyl 453 
propionic metabolite produced at a higher concentration was 3-(3´-454 
hydroxyphenyl)propionic acid, which has been identified as a strong urinary marker of 455 
red wine and grape extracts intake (Jacobs et al. 2012; Ward et al. 2004). This microbial 456 
metabolite has been shown to reduce the inflammatory response of human peripheral 457 
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blood mononuclear cells stimulated with lipopolysaccharide (Monagas et al. 2009) and 458 
to have anti-thrombotic activity (Rechner and Kroner 2005). In conclusion, this study 459 
provides data supporting the potential use of L. plantarum IFPL935 to increase gut 460 
butyrate formation and favour polyphenol metabolism in an in vitro gastro intestinal 461 
system. This opens possibilities of using the strain as a food ingredient for helping 462 
individuals showing a low polyphenol-fermenting metabotype (Bolca et al. 2013) to 463 
increase their gut capacities of metabolizing dietary polyphenols.  464 
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Legend to figures. 649 
Fig. 1. Changes in q-PCR counts (log copy number/ml) of butyrate-producing groups 650 
belonging to Clostridium clusters IV and XIVa in the ascending (AC), transverse (TC) 651 
and descending colon (DC) of the Twin-SHIME during the treatment with the red wine 652 
phenolic extract (grey squares) and the extract supplemented with L. plantarum 653 
IFPL935 (black circles) and the was out period. The dotted line indicates the end of the 654 
polyphenol treatment.  655 
Fig. 2. Changes in concentration (mM) of ammonium (circles), BCFA (squares), acetic 656 
acid (diamonds), propionic acid (triangles), butyric acid (dots) and lactic acid (asterisks) 657 
in the ascending (AC; A), transverse (TC; B) and descending colon (DC; C) of the 658 
Twin-SHIME during the treatment with the red wine phenolic extract (grey symbols) 659 
and the extract supplemented with L. plantarum IFPL935 (black symbols) and the was 660 
out period. The vertical dotted line indicates the end of  the polyphenol treatment. 661 
Fig. 3. Changes in concentration (µg/ml) of the sum of (A) precursor monomers (+)-662 
catechin and (-)-epicatechin (circles) and procyanidins B1, B2, B3, B4 (squares), (B) the 663 
intermediate metabolites phenyl-γ-valerolactones (diamonds) and phenylvaleric acid 664 
derivatives (triangles) and (C) the phenylpropionic (dots) and phenylacetic acid 665 
(asterisks) derivatives in the ascending (AC), transverse (TC) and descending colon 666 
(DC) of the Twin-SHIME during the treatment with the red wine phenolic extract (grey 667 
symbols) and the extract supplemented with L. plantarum IFPL935 (black symbols) and 668 
the was out period. The vertical dotted line indicates the end of the polyphenol 669 
treatment. 670 
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Table 1. Mean (SD) q-PCR counts (log copy number/ml) of bacterial groups in the ascending (AC), 
transverse (TC) and descending colon (DC) of the Twin-SHIME during the treatment with the red 
wine phenolic extract (Provin) and the extract supplemented with L. plantarum IFPL935 
(Provin+Lp935) and the was out period. 
Bacteria Colonic 
vessel 
Treatment Intervention period  
Day 0 
(steady state) 
Day 1 Week 1 Week 2 Week 3 
(wash out) 
Total counts AC Provin 8.28 (0.32) 7.20 (0.08) 8.28 (0.34) 7.86 (0.29) 8.03 (0.21) 
  Provin+Lp935 8.17 (0.06) 8.66 (0.07) 8.26 (0.38) 8.00 (0.31) 7.99 (0.14) 
 TC Provin 8.60 (0.12) 8.49 (0.03) 8.20 (0.38) 8.06 (0.50) 8.22 (0.30) 
  Provin+Lp935 8.42 (0.30) 8.00 (0.10) 8.23 (0.43) 8.19 (0.11) 8.06 (0.15) 
 DC Provin 8.43 (0.13) 8.33 (0.07) 8.42 (0.30) 8.34 (0.50) 8.37 (0.44) 
  Provin+Lp935 8.34 (0.25) 8.08 (0.05) 8.57 (0.14) 8.33 (0.06) 8.14 (0.42) 
Lactobacillus AC Provin 7.79 (0.41) 6.30 (0.16) 7.09 (0.29) 7.12 (0.67) 7.29 (0.30) 
  Provin+Lp935 7.57 (0.62) 7.62 (0.34) 7.40 (0.13) 7.16 (0.57) 7.69 (0.15) 
 TC Provin 7.63 (0.11) 7.16 (0.16) 6.76 (0.20) 7.29 (0.25) 7.31 (0.18) 
  Provin+Lp935 7.51 (0.13) 6.94 (0.37) 7.44 (0.05) 7.74 (0.24) 7.54 (0.29) 
 DC Provin 7.32 (0.06) 6.89 (0.02) 6.87 (0.10) 7.21 (0.41) 7.33 (0.35) 
  Provin+Lp935 7.44 (0.12) 7.03 (0.31) 7.11 (0.12) 7.55 (0.16) 7.42 (0.41) 
Bifidobacterium AC Provin 6.74 (0.40) 6.04 (0.20) 5.91 (0.68) 6.94 (0.21) 6.50 (0.80) 
  Provin+Lp935 6.73 (0.60) 6.36 (0.54) 5.44 (0.91) 6.74 (0.67) 5.96 (0.63) 
 TC Provin 6.97 (0.17)  7.01 (0.30) 6.57 (0.22) 7.31 (0.58) 7.17 (0.87) 
  Provin+Lp935 6.72 (0.15) 6.75 (0.23) 6.07 (0.17) 7.23 (0.26) 6.86 (0.70) 
 DC Provin 7.03 (0.45) 6.69 (0.39) 6.43 (0.17) 7.23 (0.43) 6.92 (0.82) 
  Provin+Lp935 6.69 (0.29) 6.52 (0.65) 6.47 (0.10) 7.13 (0.46) 6.92 (0.73) 
Bacteroides AC Provin 8.23 (0.07) 6.20 (0.05) 8.09 (0.52) 8.28 (0.08) 8.33 (0.32) 
  Provin+Lp935 8.20 (0.46) 6.23 (0.01) 8.27 (0.32) 8.11 (0.01) 8.46 (0.26) 
 TC Provin 8.47 (0.12) 7.95 (0.02) 8.28 (0.52) 8.27 (0.35) 8.37 (0.24) 
  Provin+Lp935 8.32 (0.23) 7.19 (0.07) 8.35 (0.53) 8.32 (0.08) 8.39 (0.49) 
 DC Provin 8.31 (0.14) 7.98 (0.03) 8.49 (0.24) 8.04 (0.40) 8.41 (0.25) 
  Provin+Lp935 8.37 (0.13) 7.49 (0.01) 8.68 (0.34) 8.04 (0.47) 8.00 (0.28) 
Enterobacteriaceae AC Provin 7.35 (0.21) 6.37 (0.21) 7.34 (0.33) 6.59 (0.73) 7.28 (0.19) 
  Provin+Lp935 7.15 (0.20) 7.06 (0.23) 7.52 (0.55) 6.44 (0.35) 7.25 (0.10) 
 TC Provin 7.63 (0.09) 7.40 (0.02) 7.31 (0.23) 7.15 (0.51) 7.35 (0.12) 
  Provin+Lp935 7.54 (0.26) 6.84 (0.24) 7.09 (0.29) 7.16 (0.29) 7.26 (0.27) 
 DC Provin 7.44 (0.17) 7.43 (0.23) 7.04 (0.54) 7.31 (0.34) 7.35 (0.09) 
  Provin+Lp935 7.40 (0.29) 7.01 (0.22) 6.69 (0.76) 7.25(0.28) 7.13 (0.42) 
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